What is OncoK9?
PetDx – The Liquid Biopsy Company for Pets™ is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company’s flagship product, OncoK9™, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms empowering veterinarians to provide superior care to canine patients.
Resources
To learn more about OncoK9, visit petdx.com. To access scientific resources like our white paper and peer-reviewed publications, please visit petdx.com/resources/.
Be among the first to offer this revolutionary technology
We’d love to talk with you about offering OncoK9 in your veterinary practice. Please email moc.xdtep@selas at or call (858) 224-9046.